NCT06767774View on ClinicalTrials.gov

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 25, 2025

Primary Completion Date

August 31, 2029

Study Completion Date

January 31, 2030

Conditions
ASCVDDiabetesStatin
Interventions
DRUG

Combination therapy

"* pitavastatin 4mg~* ezetimibe 10mg"

DRUG

High intensity statin monotherapy

rosuvastatin 20mg

Trial Locations (1)

02841

RECRUITING

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea University Anam Hospital

OTHER

NCT06767774 - Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus | Biotech Hunter | Biotech Hunter